Literature DB >> 24766208

A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity.

Du Hyeong Hwang1, Yong-Il Kim, Kwan Hyung Cho, Bijay Kumar Poudel, Ju Yeon Choi, Dong-Wuk Kim, Young-Jun Shin, Ok-Nam Bae, Abid Mehmood Yousaf, Chul Soon Yong, Jong Oh Kim, Han-Gon Choi.   

Abstract

A surface-attached silymarin-loaded solid dispersion with improved dissolution profile and enhanced oral bioavailability was formulated using silymarin, polyvinylpyrrolidone (PVP) and Tween 80 in water. In this solid dispersion, hydrophilic PVP was adhered onto the surface of crystalline drug rendering silymarin hydrophilic without changing its crystallinity. The drug solubility from the optimised solid dispersion prepared with silymarin/PVP/Tween 80 at the weight ratio of 5/2.5/2.5 increased by almost 650-fold compared to drug powder. The drug was physically and chemically stable in the solid dispersion for at least 6 months. Moreover, the solid dispersion enhanced the oral bioavailability of the drug in rats by almost 3-fold compared to the commercial product. The silymarin-loaded solid dispersion also exhibited advanced hepatoprotective bioactivity against CCl4-induced liver damage compared to silymarin or the commercial product. Thus, this silymarin-loaded solid dispersion would be useful for the enhancement of oral bioavailability and hepatoprotective activity of poorly water-soluble silymarin.

Entities:  

Keywords:  Bioavailability; hepatoprotection; silymarin; solid dispersion; solubility

Mesh:

Substances:

Year:  2014        PMID: 24766208     DOI: 10.3109/02652048.2014.911375

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  10 in total

Review 1.  Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review.

Authors:  Kaushika Patel; Shreeraj Shah; Jaymin Patel
Journal:  Daru       Date:  2022-04-18       Impact factor: 4.088

2.  Preparation, characterizations and anti-pollutant activity of 7,3',4'-trihydroxyisoflavone nanoparticles in particulate matter-induced HaCaT keratinocytes.

Authors:  Pao-Hsien Huang; Chih-Hua Tseng; Chia-Yu Lin; Chiang-Wen Lee; Feng-Lin Yen
Journal:  Int J Nanomedicine       Date:  2018-06-01

Review 3.  Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.

Authors:  Michal Bijak
Journal:  Molecules       Date:  2017-11-10       Impact factor: 4.411

4.  Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.

Authors:  Michal Bijak; Rafal Szelenberger; Angela Dziedzic; Joanna Saluk-Bijak
Journal:  Molecules       Date:  2018-02-10       Impact factor: 4.927

5.  Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization.

Authors:  Abid Mehmood Yousaf; Usman Rashid Malik; Yasser Shahzad; Tariq Mahmood; Talib Hussain
Journal:  J Pharm Anal       Date:  2018-09-19

Review 6.  Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.

Authors:  Alfonso Di Costanzo; Ruggero Angelico
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

7.  Enhanced Bioavailability and Efficacy of Silymarin Solid Dispersion in Rats with Acetaminophen-Induced Hepatotoxicity.

Authors:  Im-Sook Song; So-Jeong Nam; Ji-Hyeon Jeon; Soo-Jin Park; Min-Koo Choi
Journal:  Pharmaceutics       Date:  2021-04-28       Impact factor: 6.321

8.  Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.

Authors:  Gang Yang; Yaping Zhao; Yongtai Zhang; Beilei Dang; Ying Liu; Nianping Feng
Journal:  Int J Nanomedicine       Date:  2015-10-22

9.  Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.

Authors:  Michal Bijak; Ewelina Synowiec; Przemyslaw Sitarek; Tomasz Sliwiński; Joanna Saluk-Bijak
Journal:  Nutrients       Date:  2017-12-14       Impact factor: 6.706

Review 10.  Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.

Authors:  Hammad Ullah; Haroon Khan
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.